PALETTE
Palette Life Sciences, Inc.
Mark For: PALETTE® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88090174 |
| Registration Number | 1450778; 1450778A |
| Mark Literal Elements | PALETTE |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2020-10-20 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Steven C. Sereboff |
| Attorney Docket Number | B259.T18D72 |
| Law Office Assigned | M20 |
| Employee Name | DONINGER, CHRISTOPHER |
Timeline
| 2018-08-23 | Application Filed |
| 2018-12-08 | Location: TMO LAW OFFICE 111 - MANAGING ATTORNEY |
| 2018-12-08 | Status: Live/Pending |
| 2019-01-08 | Transaction Date |
| 2020-08-25 | Published |
| 2020-10-20 | Location: INTENT TO USE SECTION |
| 2021-04-20 | Status: A first request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  PALETTE LIFE SCIENCES, INC. |
| Address | 310 N Westlake Blvd., Suite 120 Westlake Village, CALIFORNIA UNITED STATES 91362 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
| Party: | Baltic Sea Life Sciences, Inc. |
| Address | 27 E. Cota Street, Suite 402 Santa Barbara DE 93101 |
| Legal Entity Type | |
| Legal Entity State | DE |
*multiple parties listed, check assignment documents for ownership information
Documents
 Drawing | IMAGE/JPEG | 2018-08-23 |
 TEAS Plus New Application | MULTI | 2018-08-23 |
| Offc Action Outgoing | MULTI | 2018-12-08 |
| XSearch Search Summary | APPLICATION/XML | 2018-12-08 |
| Response to Office Action | APPLICATION/XML | 2019-05-29 |
| Amendment and Mail Process Complete | MULTI | 2019-05-30 |
| Suspension Letter | XML | 2019-10-29 |
| Offc Action Outgoing | MULTI | 2019-12-04 |
| Response to Office Action | XML | 2020-04-01 |
| Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2020-04-03 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-07-21 |
| Notice of Publication | XML | 2020-08-05 |
| Notification Of Notice of Publication | XML | 2020-08-05 |
| OG Publication Confirmation | APPLICATION/XML | 2020-08-25 |
| Notice of Allowance | XML | 2020-10-20 |
| Extension of Time to File SOU | APPLICATION/XML | 2021-04-20 |
| ITU Extension Approval | XML | 2021-04-22 |
| ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2021-04-22 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Biological preparations for the treatment of cancer; Injectable gels for use in the treatment and repair of joint cartilage; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products for the prevention and treatment of cancer; all of the foregoing other than those produced by genome or gene editing operation
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Biological preparations for the treatment of cancer; Injectable gels for use in the treatment and repair of joint cartilage; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products for the prevention and treatment of cancer |
| GS0051 | Biological preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for use in urology; Pharmaceutical products for the prevention and treatment of cancer; all of the foregoing other than those produced by genome or gene editing operation |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-04-22 | |
| TEAS EXTENSION RECEIVED | 2021-04-20 | |
| EXTENSION 1 GRANTED | 2021-04-20 | 98765 |
| EXTENSION 1 FILED | 2021-04-20 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-10-20 | |
| PUBLISHED FOR OPPOSITION | 2020-08-25 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-08-25 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-08-05 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-07-20 | |
| ASSIGNED TO EXAMINER | 2020-06-12 | 92996 |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-04-02 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-04-01 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-04-01 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-12-04 | 6325 |
| NON-FINAL ACTION WRITTEN | 2019-12-04 | 94644 |
| NON-FINAL ACTION E-MAILED | 2019-12-04 | 6325 |
| SUSPENSION LETTER WRITTEN | 2019-10-29 | 94644 |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-10-29 | 6332 |
| LETTER OF SUSPENSION E-MAILED | 2019-10-29 | 6332 |
| ASSIGNED TO EXAMINER | 2019-10-11 | 94644 |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-05-29 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-05-29 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-05-29 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-12-08 | 6325 |
| NON-FINAL ACTION WRITTEN | 2018-12-08 | 72506 |
| NON-FINAL ACTION E-MAILED | 2018-12-08 | 6325 |
| ASSIGNED TO EXAMINER | 2018-12-08 | 72506 |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2018-10-31 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-09-01 | |
| NEW APPLICATION ENTERED IN TRAM | 2018-08-27 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 